Dhingra, Mandeep S <br/><br/>
Evaluation of the immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Shan 4) with EasyFourTM in Indian infants administered per EPI schedule: a phase III trial.  [electronic resource] 

 -  Human vaccines  Jul 2010 
 - 572-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1554-8619 
<br/><br/><label>Standard No.: </label>10.4161/hv.6.7.11817  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Bacterial--blood<br/>Diphtheria-Tetanus-Pertussis Vaccine--administration & dosage<br/>Edema--chemically induced<br/>Female<br/>Fever--chemically induced<br/>Haemophilus Vaccines--administration & dosage<br/>Humans<br/>Immunization, Secondary--methods<br/>India<br/>Infant<br/>Male<br/>Pain--chemically induced<br/>Vaccination--methods